Precision Engineered Novel Disease Treatments

Physics and AI Driven Precision Engineering of Novel Drugs

Precision engineered novel disease treatments

Drug candidates with unique properties, engineered atom by atom
The result of two decades of scientific advances
2 to 4 chemically diverse novel clinical candidates per program

Generated by the world's most advanced drug design & development platform—bar none

Learn More

Breakthrough molecular physics modeling

Integrated In Vitro and In Vivo Validation

Optimization via AI and beyond

Computer Directed Synthesis

Drug candidates that cannot be found through any other method

Changing the standard of care— for every disease we address

7 drug programs, 14 candidates—and counting . . .

Cardiovascular Disease

First-in-class Precision Oral Anticoagulants (PROACS) for currently unserved patients who need lifelong anticoagulant-antiplatelet dual therapy

Diabetic Vision Loss

First oral prophylactic in development for the prevention of progressive vision loss in diabetics

Hereditary Angioedema

Safe oral prophylactic for treatment of chronic nonallergic swelling from a rare but potentially life-threatening disease that can block airways and cause asphyxiation

Cancer–Program 1

Novel chemotherapy agents effective against multidrug-resistant tumors

Cancer–Program 2

Novel immuno oncology agents targeting gastric, renal, ovarian and other cancers that mask their presence from the immune system by overproducing adenosine in the extracellular tumor microenvironment

Cancer–Program 3

Anti-tumor drugs that prevent metastasis in highly aggressive breast, ovary, uterus, prostate, colon, cervix, skin, and other cancers

Liver Disease

Treatments for the most serious form of nonalcoholic fatty liver disease

Our growing pipeline

Physics and AI Driven Precision Engineering of Novel Drugs

Precision engineered novel disease treatments

Changing the standard of care— for every disease we address

RECENT NEWS